Cita APA

M, S., J, d. l. C., I, G., RC, Á., P, G., DF, G., . . . A, M. (2025). Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: A randomised, clinical trial design.

Citación estilo Chicago

M, Salgado, et al. Tinzaparin for the Prevention of Thromboembolic Events in Ambulatory Patients With Metastatic Colorectal Cancer Receiving First Line Treatment: A Randomised, Clinical Trial Design. 2025.

Cita MLA

M, Salgado, et al. Tinzaparin for the Prevention of Thromboembolic Events in Ambulatory Patients With Metastatic Colorectal Cancer Receiving First Line Treatment: A Randomised, Clinical Trial Design. 2025.